Keywords: merck, kgaa, 9b-euro, sale, generics, ops, mylan

Merck KGaA's 4.9B-euro sale of generics ops to Mylan completes

Article | 17 December 2007

Print This

Darmstadt, Germany-based drugmaker Merck KGaA says that it has completed the sale of its worldwide generics business to Mylan Laboratories ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in